|
January 30, 2012 - Hologic Announces First Quarter Fiscal 2012 Operating Results Read Release | Listen to Webcast January 25, 2012 - Hologic To Participate In Four Investor Conferences Read Release | Listen to Webcast January 09, 2012 - Hologic Announces Denial Of Conceptus' Request For Injunction In Patent Infringement Suit Read Release December 15, 2011 - FDA Approves Hologic's Cervista High Throughput Automation System for Cervical Cancer Screening Read Release | ||||||||||
Hologic ®, Inc.(NASDAQ: HOLX) is a leading developer, manufacturer and supplier of premium medical diagnostic equipment and medical imaging equipment, as well as surgical products dedicated to serving the healthcare needs of women throughout the world.
Breast Health
Hologic's dedication to the early detection, intervention and treatment of breast cancer is unmatched. Solutions range from
Selenia
®
digital mammography systems and
computer aided detection to the
MammoPad
® breast cushion.
Selenia
Dimensions
® is the first commercially available tool to deliver on the extraordinary promise of
breast tomosynthesis. The system features one-touch control for seamless, instantaneous transition between imaging modes:
full-field digital mammography (2D imaging),
breast tomosynthesis (3D imaging), or "combo-mode" imaging (2D+3D imaging), Hologic's unique feature that quickly acquires a traditional digital mammogram and a
breast tomosynthesis scan in the same compression.
To aid in a timely and efficient breast cancer diagnosis, Hologic also offers
breast biopsy equipment that may be used under all three imaging modalities,
stereotactic,
ultrasound, and
MRI. If breast cancer is caught early enough, breast brachytherapy treatments, like
MammoSite
® five-day targeted radiation therapy may be an alternative to whole breast irradiation or a mastectomy.
Gynecological Health
Hologic is working for women's health on several fronts, including cervical cancer screening. Together the
ThinPrep
® Pap test and the
Cervista HPV (human papilloma virus) test deliver a more accurate cervical cancer screening solution.
Adiana
® Permanent Contraception is a safe and simple hysteroscopic procedure that provides women with permanent contraception.
Our
MyoSure
® hysteroscopic tissue removal system is an effective and less invasive solution for women who may think a hysterectomy is the only solution.
NovaSure
® is a one-time, five-minute procedure that can lighten or end your heavy period.
Prenatal Health
Hologic's
fetal fibronectin test is a well-established aid in assessing preterm birth risk - it provides valuable information that may support management and treatment options for the mother. Hologic also offers a second important test for women during pregnancy called
InPlex CF
®: it is a molecular test that can identify genetic mutations associated with cystic fibrosis.
Skeletal Health
Osteoporosis is a growing healthcare crisis affecting millions of women and men worldwide. Fortunately, bone density testing is safe and non-invasive and when osteoporosis is detected early, it is treatable. Hologic offers
bone density equipment that provides a broad spectrum of care of patients in a single platform. Our bone densitometry systems not only help manage your patient's bone health, but also
obesity and
visualization of calcifications in the abdominal aorta that may indicate heart disease, and many other clinical applications.
We've taken our commitment to bone health one step further with our
Fluoroscan mini C-arm imaging and
extremity MRI systems.
Laboratory Solutions
Hologic is committed to providing laboratories with the most innovative and effective technologies, as well as best-in-class customer service. Our
ThinPrep Pap
® test revolutionized cervical cancer screening a decade ago and now the
ThinPrep imaging system is becoming the new standard of care in cytology, utilizing computer technology, automatically scanning every cell and cell cluster, to highlight areas of interest for human analysis.
The
Cellient
® automated cell block system is the first fully automated cell block system. The vacuum-assisted filtration concentrates available cells within the block. The result is diagnostically useful, higher-quality blocks that can be reviewed efficiently - all in under an hour.
Hologic's molecular solutions are based on the company's proprietary Invader
® chemistry, a robust and versatile technology.
Cervista HPV HR and Cervista HPV 16/18 are FDA approved tests that provide improved reliability and productivity to laboratory customers.
Invader chemistry also powers
InPlex CF
®, our test for cystic fibrosis mutation carrier screening, as well as genetic tests associated with blood coagulation, thrombophilia, and other applications.